Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Method of modulating the adrenomedullin (ADM) activity of a patient by administering to the patient an anti-ADM antibody or fragment thereof that specifically binds to mature human ADM

US Patent 11673949 · Granted Jun 13, 2023

Assignee

Inventors

View full patent text on Google Patents →